低性T细胞驱动小鼠和人类内源性瘤免疫力
Summit Singhaviranon1, Joseph P Dempsey1, Adam T Hagymasi1
1Department of Immunology and Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, CT, USA.
Nature immunology
|January 9, 2025
概括
低性T细胞控制癌症,并响应检查点封锁,而高性T细胞是抑制性的. 狂热度评分可以识别这些独特的T细胞种群,以改善癌症免疫治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- T细胞生物学T细胞生物学
背景情况:
- T细胞通过T细胞受体 (TCR) - - 主性基因相容复合体 (pMHC) 相互作用来识别癌细胞.
- 这种TCR-pMHC相互作用的强度或强度对于有效的抗癌免疫是至关重要的.
研究的目的:
- 调查低贪性与高贪性CD8+ T细胞在癌症控制中的不同作用.
- 确定T细胞激发差异背后的机制及其对免疫反应的影响.
- 为潜在的治疗应用开发一种识别T细胞狂热状态的方法.
主要方法:
- 在小鼠模型中分析具有不同性的新表位特异性CD8+ T细胞.
- 评估T细胞对检查点阻塞疗法的反应.
- 对高贪性T细胞进行转录形状分析,以获得"贪性得分".
- 在小鼠和人类数据集中的低度和高度T细胞的in silico识别.
主要成果:
- 低度的CD8+ T细胞是癌症控制的主要媒介,对检查点阻塞有反应.
- 高度的CD8+ T细胞对抗癌症无效,并表现出免疫抑制性质.
- 高贪的T细胞表现出更高的疲劳状态.
- 从转录基因数据中获得的"敏度得分"成功地区分了低敏度和高敏度的T细胞.
- 具有相同TCR的CD8+T细胞表现出的显著差异,表明复杂的调节机制.
结论:
- 抗癌免疫力和对免疫治疗的反应的关键决定因素是T细胞激发率.
- 高性T细胞有助于瘤微环境中的免疫抑制.
- 开发的"贪度评分"为癌症患者的T细胞种群分层提供了一个新的工具.
- 了解T细胞狂热度变异可以指导开发更有效的癌症免疫疗法.
相关概念视频
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
Cytotoxic T Cells-mediated Immune Response
841
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
841
T Cell Activation and Clonal Selection
651
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
651


